Benefit-risk assessment of incretin and other anti-diabetic agents in type 2 diabetes using a stochastic multicriteria acceptability analysis model.

ABSTRACT:

SUBMITTER: Chai S 

PROVIDER: S-EPMC10106192 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature